Last reviewed · How we verify

NCT06911541

Clinical Validation of a Novel, Accelerometer Based, Continuous Respiratory Rate Sensor

Completed NA Last updated 13 August 2025
What this trial tests

NA trial testing Wireless respiratory rate monitor in Respiratory Rate Accuracy Test in 29 participants. Completed in 10 August 2025.

Timeline
16 May 2025
Primary endpoint
15 June 2025
10 August 2025

Quick facts

Lead sponsorEupnea AS
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment29
Start date16 May 2025
Primary completion15 June 2025
Estimated completion10 August 2025
Sites1 location across Norway

Drugs / interventions tested

Conditions studied

Sponsor

Eupnea AS

Who can join

18 and older, any sex, with Respiratory Rate Accuracy Test or Capnography. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparing a wireless accelerometer-based sensor that continuously measure breathing rate with the gold standard capnography. The aim is to evaluate if both methods are equivalent.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Clinical validation of a novel accelerometer-based respiratory rate monitor.
    Steihaug OM, Sjøset TE, Stordal AS, Sleire AD, et al · · 2026 · PMID 41649789 · DOI 10.1007/s10877-026-01419-x

Verify or expand the search:

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06911541.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing